A Speedinvest portfolio company

Flinn

Sector
Health & Bio
Year Invested
2022
Enabling MedTech companies to automate quality & regulatory processes to launch and operate products 10x more efficiently.

Flinn's vision is to make high-quality health products accessible for everyone. The first major milestone on this journey is to enable medical device manufacturers to automate quality and regulatory processes. The go-to-market product sets the focus on the automation of post-market surveillance processes. This means automating the collection, evaluation, and reporting of relevant data through smart workflows, integrations, and the support of AI.

Austria
Share
Links
LinkedIn
Related Companies
hi.health

Convenient and safe access to private health insurance billing.

Sector
Health & Bio
Exits
AI & Infra
Year Invested
2019
IOMED

Better ICD-10 coding and big data insights for hospitals.

Sector
Health & Bio
AI & Infra
Year Invested
2018
Juli

Improving life for people with chronic conditions.

Sector
Health & Bio
Year Invested
2022
MiLaboratories

The leader in immunome data analysis software with flagship product MiXCR.

Sector
Deep Tech
Health & Bio
Year Invested
2022
Molecule

Connecting life science research to funding.

Sector
Health & Bio
Year Invested
2022
Mpiriq

MPIRIQ links everyday clinical data with medical research to turn routine patient care into insights that accelerate new therapies.

Sector
Health & Bio
Year Invested
2024
NeuroHarmonics

Building the future of non-invasive neuromodulation using focused ultrasound to modulate deep brain circuits safely.

Sector
Health & Bio
Year Invested
2025
Nilo Health

The mental well-being support for your entire workforce.

Sector
Health & Bio
Marketplaces & Consumer
Year Invested
2022